Fubei Biotechnology (Suzhou)
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- Undisclosed
Investors
- 6
About Fubei Biotechnology (Suzhou)
Established in 2017 and based in Suzhou, China, Fubei Biotechnology (Suzhou) operates as a neurological drug developer dedicated to providing novel medicines for neurodegenerative diseases and neurological injuries. The co-founder and CEO, Xiaoming Guan, has 27 years of R&D and leadership experience in the pharmaceutical industry. Up to now, there are 9 innovative projects in the R&D pipeline, including small-molecule chemical drugs and large-molecule biologics. In addition, potential drug candidates FB1003 and FB1008 for the treatment of chronic pain and Alzheimer's disease are in the preclinical stage.
Who invested in Fubei Biotechnology (Suzhou)
6 investors across 1 round
See all investors in Fubei Biotechnology (Suzhou)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 10, 2021
Amount
Undisclosed
Investors
Questions about Fubei Biotechnology (Suzhou)
Who invested in Fubei Biotechnology (Suzhou)?
Fubei Biotechnology (Suzhou) has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fubei Biotechnology (Suzhou) raised?
Fubei Biotechnology (Suzhou) has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Fubei Biotechnology (Suzhou) last raise money?
Fubei Biotechnology (Suzhou)'s most recent round on record is a Series A, in Feb 2021.
What does Fubei Biotechnology (Suzhou) do?
Established in 2017 and based in Suzhou, China, Fubei Biotechnology (Suzhou) operates as a neurological drug developer dedicated to providing novel medicines for neurodegenerative diseases and neurological injuries.
Where is Fubei Biotechnology (Suzhou) headquartered?
Fubei Biotechnology (Suzhou) is headquartered in Suzhou, China.
Which VCs invest in companies like Fubei Biotechnology (Suzhou)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Fubei Biotechnology (Suzhou)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Fubei Biotechnology (Suzhou)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.